home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Genome editing successfully used to induce chicory plants to accumulate important medical compound


Wageningen, The Netherlands
September 20, 2022

 


An international research team from KeyGene and Wageningen University & Research, both in the Netherlands, and Leibniz Institute of Plant Biochemistry in Germany, have developed chicory plants that accumulate costunolide, a plant metabolite known for its anti-cancer activity. The scientists used the genome editing technique CRISPR Cas9 to block further processing of costunolide into other plant metabolites, resulting in the accumulation of the medical compound. The team published their results in a paper in Frontiers in Plant Science.

Costunolide was first extracted from Saussurea costus, a wild plant growing in the Himalayas, which is now cultivated in India, having a low yield.

Chicory also produces costunolide but it does not accumulate because the metabolite is, serving as an intermediate, in the taproots rapidly converted to bitter-tasting metabolites belonging to the sesquiterpene lactones. For the production of these metabolites, the step from costunolide to kauniolide is crucial. This step is established by the enzyme kauniolide synthase. The research team identified three copies of the gene that codes for this enzyme.

All three of these copies are important: only after blocking the activity of all of the three, using CRISPR/Cas9, the production of kauniolide was blocked. This resulted in an accumulation of costunolide in the taproots of the chicory plants.

Read the full paper in Frontiers in Plant Science (open access).

This research is part of the EU-financed research project CHIC, which is coordinated by Wageningen University & Research. CHIC aims to support the establishment of a responsible innovation pathway for the development and application of New Plant Breeding Techniques (NPBTs) for chicory as a multipurpose crop for the production of high-value consumer products, in line with societal needs and concerns. The CHIC research consortium includes SMEs, an industrial partner, non-profit organizations, and research institutes from 11 European countries and one from New Zealand.

 



More news from:
    . KeyGene NV
    . Wageningen University & Research


Website: http://www.keygene.com

Published: September 20, 2022

The news item on this page is copyright by the organization where it originated
Fair use notice


Copyright @ 1992-2024 SeedQuest - All rights reserved